Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
YT
Y-mAbs Therapeutics A/S
aktivCVR 37053678AktieselskabAgern Alle 13, 2970 HørsholmForskning og eksperimentel udvikling inden for naturvidenskab og teknik
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 06 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Not available from the published filing—
Not available from the published filing
Operating profit
DKK -48.1m
Latest period
Source details
Source: dk-regnskabsdata-live-37053678-1793950181075
Document: dk-regnskabsdata-37053678-AZ7-KbVTJsD7XaxeaM9s-1
XBRL: d:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c1
Unit: u5
Net result
DKK -38.5m
Latest period
Source details
Source: dk-regnskabsdata-live-37053678-1793950181075
Document: dk-regnskabsdata-37053678-AZ7-KbVTJsD7XaxeaM9s-1
XBRL: d:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c1
Unit: u5
Equity
DKK -163.7m
Equity ratio: -1,087.9%
Source details
Source: dk-regnskabsdata-live-37053678-1793950181075
Document: dk-regnskabsdata-37053678-AZ7-KbVTJsD7XaxeaM9s-1
XBRL: d:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c7
Unit: u5
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK -85.7m |
| 2023 | — | DKK -27.7m |
| 2024 | — | DKK -12.5m |
| 2025 | — | DKK -38.5m |